Abstracts

>> Poster recommendations (PDF) <<

Submission Process

• Delegates, who would like to present their work at the Congress, either orally or as a poster, are invited to submit an abstract for consideration by the Abstract Grading Committee.

• A paper should not be submitted to the 37^th ESPEN Congress if it has already been presented internationally.

• Abstract submission is only possible via the on-line abstract submission form.

• Please read carefully all the instructions available on the Internet and on the on-line abstract submission system before preparing your abstract.

• The creation of a user account is required for the submission of an abstract. The account only needs to be created once and can be re-used for future abstract submission and registration to the conference. Submitters from last year’s meeting should use their existing account details.

• Abstracts can be saved in “Draft status” to be re-edited and modified until the submission deadline (7 April 2015, Midnight CET). Abstracts cannot be edited after the submission deadline.

• Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be considered for the Congress.

• Abstracts are accepted on a wide range of topics in clinical nutrition and metabolism. The submitter has to select the right topic for the abstract on the submission form. Available topics are:

1. Nutritional assessment
2. Nutritional epidemiology
3. Carbohydrate and lipid metabolism
4. Protein and amino acid metabolism
5. Hormones, mediators and immunity
6. Vitamins, antioxidants and minerals
7. Critical Care
8. Liver and gastrointestinal tract
9. Nutrition and chronic diseases
10. Obesity and the metabolic syndrome
11. Nutrition and cancer
12. Paediatrics
13. Nutritional techniques and formulations
14. Geriatrics
15. Qualitative design studies
16. Perioperative care
17. Late Breaking Abstract

For standardisation, the acceptable length of the abstract is of not more than 2’000 printable characters (headers, conflicts of interest, title, etc. included). This includes non-visible characters, such as spaces and line breaks. Authors’ details are not included.

Please refer to the word count of the system as slight differences may occur when counting with WORD or similar programmes.

The abstract needs to be structured as follows:

• Rationale: this section should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.

• Methods: this section should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.

• Results: this section should contain objective data to answer the scientific question(s).

• Conclusions: this section should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralisation.

One table can be included, but the total number of cells (columns + rows) may not exceed 16. Please note that tables may significantly reduce the number of the remaining allowed characters.

A paper cannot be accepted if the conflict of interest disclosure is not signed. On the on-line abstract form, provide the requested details for all authors.

Rules

The rules for preparing the abstracts can also be found on this site. Failure to observe these guidelines may result in disqualification.

Late breaking abstracts

Late breaking abstracts may be accepted until 19 June 2015, Midnight, CET with a non-refundable fee of EURO 100.- that has to be paid upon submission. The fee is applicable although the abstract is accepted or not.

Late breaking abstracts will only be presented as posters.

Late breaking abstracts are also published either in the Supplement or in the next coming issue of the Journal.

Presentation of abstracts

• Abstracts can be accepted either as poster or oral communication.

• The Abstract Grading Committee will select submitted abstracts and determine whether they are accepted for oral or poster presentation.

• If your abstract is accepted as a poster, you will be requested to be available for discussion during the corresponding poster viewing session.

• The maximum usable surface of the display panels is 150cm (height) x 95cm (width), however the recommended size is 100cm high x 94cm large. The Adhesive material will be provided.

• Please use letters large enough to be read from a distance of 1.5 meters.

Publication

Accepted abstracts will be published in the Supplement of Clinical Nutrition, "Nutrition and Metabolism - the ESPEN Journal", and will be available on the Internet one month prior to the Congress as submitted by the authors.

General Remarks

• The Author of the abstract selected for presentation must be registered at the Congress.

• Abstracts must contain data and meet international ethical standards.

• Abbreviations should be defined.

• Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.

• Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proof reading will be done.

• No changes can be made to the abstract after the submission deadline 7 April 2015, midnight CET.

• The reviewers will judge the abstracts according to the relevance to ESPEN, standard of English, objectivity of statements, description of what was done, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.

• Submitting authors will be notified by 30 May 2015 whether their abstract has been accepted, and they will be informed at the same time about the date, time and form of their presentation. All notifications will be sent out to the e-mail address given on the submission form.

• If you want to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the ESPEN Secretary espen.scienti@mci-group.com no later than 1 June 2015.